Qi Li
Fujian Medical University(CN)Nanfang Hospital(CN)Wuhan Third Hospital(CN)First Hospital of China Medical University(CN)Fujian Provincial Hospital(CN)Southern Medical University(CN)China Medical University(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, T-cell and B-cell Immunology, Nutrition and Health in Aging, Immune Cell Function and Interaction, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → <p>Safety and Efficacy of Camrelizumab Combined with Apatinib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Multicenter Retrospective Study</p>(2020)49 cited
- → A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma(2024)32 cited
- → The impact of sarcopenia on the outcome of patients with left-sided colon and rectal cancer after curative surgery(2023)17 cited
- → Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study(2023)12 cited
- → Association between diabetes and disease severity in patients with venomous snakebites: A Multicenter Retrospective Analysis(2025)
- → γδ T cells in diabetes mellitus: dual roles and therapeutic implications